January 31st Deadline: Important Customs Update regarding Entry Summary Declarations for Safety and Security.
23 Dec 2024
Read more >Pharma industry manufacturers are considering how advanced therapy medicinal products (ATMPs) and other traditional modalities can be combined within the same facility or within a newly constructed agnostic building.
PM Group\\\’s Tom Bannon, Advanced Therapies SME, and Alf Penfold, Regulatory SME, address these and other questions related to multi-modality manufacturing.
To read more, follow the link below.
External URL: https://www.pmgroup-global.com/news/multi-modality-manufactur/index.xml
By PM Group
431 Views